Effects of Crystalline State and Self-Nanoemulsifying Drug Delivery System (SNEDDS) on Oral Bioavailability of the Novel Anti-Hiv Compound 6-Benzyl-1-benzyloxymethyl-5-iodouracil in Rats.
Ying-Yuan Lu,Wen-Bing Dai,Xin Wang,Xiao-Wei Wang,Jun-Yi Liu,Pu Li,Ya-Qing Lou,Chuang Lu,Qiang Zhang,Guo-Liang Zhang
DOI: https://doi.org/10.1080/03639045.2017.1391837
IF: 3.727
2017-01-01
Drug Development and Industrial Pharmacy
Abstract:The objective of this study was to investigate the effect of crystalline state and a formulation of self-nanoemulsifying drug delivery system (SNEDDS) on oral bioavailability of 6-benzyl-1-benzyloxymethyl-5-iodouracil (W-1), a novel non-nucleoside reverse transcriptase inhibitor, in rats. The crystalline states of W-1 were characterized by scanning electron microscope (SEM), differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD). The SNEDDS was formulated by medium-chain lipids, characterized by droplet particle size. The plasma concentrations of W-1 were measured by high performance liquid chromatography (HPLC). The results indicated that W-1 compound were presented as crystalline forms, A and B, the degree of crystallization in form B was higher than that in form A. The SNEDDS of W-1 displayed a significant increase in the dissolution rate than W-1 powder. Furthermore, after oral administration of W-1 (100mg/kg), the pharmacokinetic parameters of form A, form B, and W-1 SNEDDS were as follows: AUC(0-t) 526.4 +/- 123.5, 305.1 +/- 58.5 and 2297 +/- 451 ngh/ mL (p<.05, when W-1 SNEDDS were compared with either form A or form B), respectively. With SNEDDS formulation, the relative bioavailabilities were enhanced by 4.36-fold and 7.53-fold over the form A and form B of W-1, respectively. In conclusion, the present results suggested that the crystalline states of W-1 might lead to the lower oral bioavailability, and SNEDDS formulation is a promising strategy of improving bioavailability, in spite of that crystalline states usually carry small lot-to-lot variability.